Shom Goel

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 15

Top Topics

Positive Breast Cancer

Top Venues

The Journal of experimental medicine

Future oncology (London, England)

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Bojana Jovanovic, Sarah E Church, Kara M Gorman, Khrystyna North, Edward T Richardson, Molly DiLullo, Victoria Attaya, Julie Kasparian, Ayesha Mohammed-Abreu, Gregory Kirkner, Melissa E Hughes, Nancy U Lin, Elizabeth A Mittendorf, Stuart J Schnitt, Sara M Tolaney, Shom Goel
Integrative multi-omic profiling of triple-negative breast cancer for identifying suitable therapies. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Kamilla Fjermeros, Salim Ghannoum, Stephanie B Geisler, Sameer Bhargava, Andliena Tahiri, Jovana Klajic, Torben Lüders, Marie Fongård, Meh Sameen Nawaz, Tatjana Bosnjak-Olsen, Unn-Cathrin Edvardsen Buvarp, Aino Katri Johanna Rosenskiold, Nam Thi Nguyen, Tone Tysko Sletbak, Manouchehr Seyedzadeh, Knut Selsås, Alina Carmen Porojnicu, Helle Kristine Skjerven, Tone Hovda, Kristine Kleivi Sahlberg, Lilly Anne Torland, Marianne Lyngra, Clara Louise Hammarström, Elma Bahonjic Hönigsperger, John Christopher Noone, Silje Mathiassen, Antoni Hurtado, Shom Goel, Andrew Koff, Xavier Tekpli, Vessela N Kristensen, Jürgen Geisler
The NEOLETRIB trial: neoadjuvant treatment with Letrozole and Ribociclib in ER-positive, HER2-negative breast cancer. Future oncology (London, England) (2024)
Lestat R Ali, Ana Christina Garrido-Castro, Patrick J Lenehan, Naima Bollenrucher, Courtney T S Kureshi, Michael L Dougan, Shom Goel, Geoffrey I Shapiro, Sara M Tolaney, Stephanie K Dougan
PD-1 blockade and CDK4/6 inhibition augment nonoverlapping features of T cell activation in cancer. The Journal of experimental medicine 220 (4) (2023)
Sara M Tolaney, Shom Goel, Jorge Nadal, Hannelore G Denys, Manuel Ruiz Borrego, Lacey M Litchfield, Jiangang Liu, Adams K Appiah, Yanyun Chen, Fabrice Andre
Overall survival and exploratory biomarker analyses of abemaciclib plus trastuzumab with or without fulvestrant vs trastuzumab plus chemotherapy in HR+, HER2+ metastatic breast cancer patients. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Catherine Dietrich, Alec Trub, Antonio Ahn, Michael Taylor, Krutika Ambani, Keefe T Chan, Kun-Hui Lu, Christabella A Mahendra, Catherine Blyth, Rhiannon Coulson, Susanne Ramm, April C Watt, Sunil Kumar Matsa, John E Bisi, Jay Strum, Patrick Roberts, Shom Goel
INX-315, a selective CDK2 inhibitor, induces cell cycle arrest and senescence in solid tumors. Cancer discovery (2023)
Lestat R Ali, Ana Christina Garrido-Castro, Patrick J Lenehan, Naima Bollenrucher, Courtney T S Kureshi, Michael L Dougan, Shom Goel, Geoffrey I Shapiro, Sara M Tolaney, Stephanie K Dougan
PD-1 blockade and CDK4/6 inhibition augment nonoverlapping features of T cell activation in cancer. The Journal of experimental medicine 220 (4) (2023)
Lestat R Ali, Ana Christina Garrido-Castro, Patrick J Lenehan, Naima Bollenrucher, Courtney T S Kureshi, Michael L Dougan, Shom Goel, Geoffrey I Shapiro, Sara M Tolaney, Stephanie K Dougan
PD-1 blockade and CDK4/6 inhibition augment nonoverlapping features of T cell activation in cancer. The Journal of experimental medicine 220 (4) (2023)
Lestat R Ali, Ana Christina Garrido-Castro, Patrick J Lenehan, Naima Bollenrucher, Courtney T S Kureshi, Michael L Dougan, Shom Goel, Geoffrey I Shapiro, Sara M Tolaney, Stephanie K Dougan
PD-1 blockade and CDK4/6 inhibition augment nonoverlapping features of T cell activation in cancer. The Journal of experimental medicine 220 (4) (2023)
Lestat R Ali, Ana Christina Garrido-Castro, Patrick J Lenehan, Naima Bollenrucher, Courtney T S Kureshi, Michael L Dougan, Shom Goel, Geoffrey I Shapiro, Sara M Tolaney, Stephanie K Dougan
PD-1 blockade and CDK4/6 inhibition augment nonoverlapping features of T cell activation in cancer. The Journal of experimental medicine 220 (4) (2023)
Lestat R Ali, Ana Christina Garrido-Castro, Patrick J Lenehan, Naima Bollenrucher, Courtney T S Kureshi, Michael L Dougan, Shom Goel, Geoffrey I Shapiro, Sara M Tolaney, Stephanie K Dougan
PD-1 blockade and CDK4/6 inhibition augment nonoverlapping features of T cell activation in cancer. The Journal of experimental medicine 220 (4) (2023)
April C Watt, Shom Goel
Cellular mechanisms underlying response and resistance to CDK4/6 inhibitors in the treatment of hormone receptor-positive breast cancer. Breast cancer research : BCR 24 (1) (2022)
Shom Goel, Antoinette R Tan, Hope S Rugo, Philippe Aftimos, Zoran Andrić, Andrew P Beelen, Jingshan Zhang, John S Yi, Rajesh K Malik, Joyce O'Shaughnessy
Trilaciclib prior to gemcitabine plus carboplatin for metastatic triple-negative breast cancer: phase III PRESERVE 2. Future oncology (London, England) (2022)
Shom Goel, Johann S Bergholz Villafane, Jean J Zhao
Targeting CDK4 and CDK6 in cancer. Nature reviews. Cancer 22 (6) (2022)
Khalid El Bairi, Harry R Haynes, Elizabeth Blackley, Susan Fineberg, Jeffrey Shear, Sophia Turner, Juliana Ribeiro de Freitas, Daniel G Sur, Luis Claudio Amendola, Masoumeh Gharib, Amine Kallala, Indu Arun, Farid Azmoudeh-Ardalan, Luciana Fujimoto, Luz F Sua, Shi-Wei Liu, Huang-Chun Lien, Pawan Kirtani, Marcelo Balancin, Hicham El Attar, Prerna Guleria, Wenxian Yang, Emad Shash, I-Chun Chen, Veronica Bautista, Jose Fernando Do Prado Moura, Bernardo L Rapoport, Carlos Castaneda, Eunice Spengler, Gabriela Acosta-Haab, Isabel Frahm, Joselyn Sanchez, Miluska Castillo, Najat Bouchmaa, Reena R Md Zin, Ruohong Shui, Timothy Onyuma, Wentao Yang, Zaheed Husain, Karen Willard-Gallo, An Coosemans, Edith A Perez, Elena Provenzano, Paula Gonzalez Ericsson, Eduardo Richardet, Ravi Mehrotra, Sandra Sarancone, Anna Ehinger, David L Rimm, Timothy J Whelan, Giuseppe Viale, Carsten Denkert, Akira I Hida, Christos Sotiriou, Sibylle Loibl, Stephen M Hewitt, Sunil S Badve, William Fraser Symmans, Rim S Kim, Giancarlo Pruneri, Shom Goel, Prudence A Francis, Gloria Inurrigarro, Rin Yamaguchi, Hernan Garcia-Rivello, Hugo Mark Horlings, Said Afqir, Roberto Salgado, Sylvia Adams, Marleen Kok, Maria Vittoria Dieci, Stefan Michiels, Sandra Demaria, Sherene Loi, null null
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group. NPJ breast cancer 7 (1) (2021)
Max Heckler, Lestat R Ali, Eleanor Clancy-Thompson, Li Qiang, Katherine S Ventre, Patrick Lenehan, Kevin Roehle, Adrienne Luoma, Kelly Boelaars, Vera Peters, Julia McCreary, Tamara Boschert, Eric S Wang, Shengbao Suo, Francesco Marangoni, Thorsten R Mempel, Henry W Long, Kai W Wucherpfennig, Michael Dougan, Nathanael S Gray, Guo-Cheng Yuan, Shom Goel, Sara M Tolaney, Stephanie K Dougan
Inhibition of CDK4/6 Promotes CD8 T-cell Memory Formation. Cancer discovery 11 (10) (2021)